dc.creatorRanuncolo, Stella Maris
dc.date.accessioned2017-06-08T16:04:48Z
dc.date.accessioned2018-11-06T12:04:15Z
dc.date.available2017-06-08T16:04:48Z
dc.date.available2018-11-06T12:04:15Z
dc.date.created2017-06-08T16:04:48Z
dc.date.issued2016-04
dc.identifierRanuncolo, Stella Maris; Towards the dreamed biomarkers?; OMICS International; Journal of Molecular Biomarkers & Diagnosis; 7; e124; 4-2016; 1-3
dc.identifier2155-9929
dc.identifierhttp://hdl.handle.net/11336/17783
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1862795
dc.description.abstractDetection and determination of tumor biomarkers are made from tissue and blood collection. During the last decade new biological sources are feasible: circulating tumor cells and circulating nucleic acids. They are composing a new field named as liquid biopsy. The availability of next-generation sequencing and Digital-PCR among other techniques, led to the possibility of getting the most out of this “circulating material” that would mirror the genetic and epigenetic features of the tumor.
dc.languageeng
dc.publisherOMICS International
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.omicsonline.org/open-access/towards-the-dreamed-biomarkers-2155-9929-S2-e002.php?aid=74872
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.4172/2155-9929.S2-e002
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectLIQUID BIOPSY
dc.subjectBIOMARKERS
dc.titleTowards the dreamed biomarkers?
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución